Effectiveness of Homeopathic Treatment in Female Infertility

June 2, 2018 updated by: Dr Anita Fernandes, Fr Muller Homoeopathic Medical College

A Clinical Study to Assess the Effectiveness of Homeopathic Treatment in Female Infertility

The purpose of this study is to assess the effectiveness of Homoeopathic treatment in female infertility.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Objectives:

• To assess the rate of conception, in female infertility, after individualized homoeopathic treatment.

Need for the study:

  • To confirm that homeopathy is best alternative for resource limited community to receive effective treatment with minimum possible expenditure.
  • To bring out a repertoire of effective Homoeopathic medicines in the treatment of infertility.
  • To establish a centre for focussed treatment of infertility at Father Muller Homeopathic Medical College and Hospital.

Many cases visiting Homoeopathic OPD have improved under the treatment. In general, there is a deficit of well-designed, randomized, controlled trials to evaluate the efficacy and safety of complementary and alternative medicine for these indications, which makes it difficult to provide evidence-based recommendations.

Globally there is a need for this study to avoid the side-effects of antibiotics and hormonal tablets thus improving the quality of life. In a third world country like India where infertile females cannot afford surgery; Homoeopathic medicines are simple, safe and cost effective. Homoeopathy can treat the underlying cause of female infertility in these cases and thereby prevent the hazards of surgery. In India the female race is always targeted and blamed for being infertile. This not only has an impact on the health of the woman but also affects her social status. The psychological and mental agony suffered by these infertile women and the fear that their husbands' may go in for a second marriage in turn causes great stress and anxiety. Hence the efficacy of Homoeopathic medicines on infertile females needs to be explored.

Methodology:

Approach: This is a prospective study with purposive sampling. Design: Total number of beneficiaries is 40, including 20 PCOS cases, 10 cases of Endometriosis, and 10 cases of Chronic Pelvic Inflammatory diseases. The numbers of these cases are based on the availability and frequency of their visits to our OPD.

Data collection instruments: case books of the OPD Setting: OPD of Homeopathic Medical College, Derlakatte, Kankanady and Thumbe Population: women visiting the OPD for infertility treatment Sample: women diagnosed for any of the three causes of infertility Sampling technique: purposive sampling Feasibility: the study is feasible in terms of availability of patients at our OPD settings Duration of study: total of 3 years. All 40 cases are expected to be registered in a span of 6 months to 1 year. Registration will be followed by treatment of 18 months, 6 months for analysis and reporting by the end of 3 years.

Statistical analysis: Data from the sample is collected and subjected to chi square test, and frequencies will be calculated.

Null Hypothesis: No significant difference in cases of female infertility before and after treatment.

Alternate Hypothesis: Significant difference in cases of female infertility before and after treatment.

Procedure:

Forty infertile women will undergo investigations like Ultrasonography of pelvis, diagnostic laparoscopy when needed and urine pregnancy test once in six months. The cases will be diagnosed by the principal investigators and co-investigators. Semen analysis in male partners will be done as a routine to rule out cases of male infertility. The infertile women will be administered appropriate Homoeopathic Simillimum by the principal investigator for 18 months. The follow-up visits of these patients will be once in two weeks. Effectiveness of Homoeopathic treatment and rate of conception in infertile females will be assessed after administering the Simillimum. The investigations will be repeated after treatment and cases will be reviewed and examined by the co-investigators.

The treatment given is individually chosen homoeopathic medicine based on the psychophysical symptom syndrome each experienced. The drugs are procured from Fr Muller HPD which complies with the standards of Homoeopathic Pharmacopoeia. The investigations will be repeated after treatment.

The Homoeopathic treatment includes a detailed interview in which the patient is queried about her unique symptoms. The well indicated constitutional remedy will be given on the basis of symptoms' similarity, that is, symptoms that were in emotional and mental realm and those that affected her entire body. The symptoms will be ordered by intensity and prominence. A single dose of Homoeopathic Similimum will be given to each of these patients and repeated as and when needed and whenever required the potency will be increased. If there is any miasmatic block, anti-miasmatic treatment will be given. Acute remedy will be given when needed. All cases of infertility are told to abstain from caffeine and Allopathic treatment. Hormonal treatment is to be withdrawn. The investigations will be repeated after treatment after six months, twelve months and eighteen months whenever required to assess the improvement of the patient.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karnataka
      • Mangalore, Karnataka, India, 575018
        • Fr Muller Homoeopathic Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Inclusion criteria:

    • Only female causes
    • Age group of 18-40 years
    • Cases of PCOS, Endometriosis and Chronic PID
    • Primary and secondary infertility

Exclusion Criteria:

  • Age group below 18 years and beyond 40 years
  • All other causes such as unknown infertility, congenital defects
  • Women whose husband's semen analysis is abnormal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Homoeopathic medicines
4 pills once a week of the indicated similium for a period of one year
4 pills once a week of the indicated Similimum
Other Names:
  • indicated Homoeopathic similimum

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improved fertility rate
Time Frame: 3 years
Investigative parameters becoming normal
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive pregnancy test
Time Frame: 3 years
Earlie Icon
3 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conception
Time Frame: 3 years
Live intra-uterine foetus
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr Anita Fernandes, MD(HOM), Fr Muller Homoeopathic Medical College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

June 25, 2014

First Submitted That Met QC Criteria

June 25, 2014

First Posted (Estimate)

June 26, 2014

Study Record Updates

Last Update Posted (Actual)

June 6, 2018

Last Update Submitted That Met QC Criteria

June 2, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APB123

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Infertility

Clinical Trials on Homoeopathic medicines

3
Subscribe